Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation.
Explore this paper's citation graph
Summary
The strategy of adding clopidogrel to aspirin for 3 months after TAVI was not found to be superior to aspirin alone, and these results must be confirmed in a larger randomized trial.
- Type
- article
- Published
- 2011-12-15
- Cited by
- 262
- References
- 12
- OpenAlex
- https://openalex.org/W1976766529
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:22813671
Keywords
Medicine, Aspirin, Clopidogrel, Stroke (engine), Myocardial infarction
References
- Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients.
- Is early anticoagulation with warfarin necessary after bioprosthetic aortic valve replacement?
- Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement.
- Postprocedural management of patients after transcatheter aortic valve implantation procedure with self‐expanding bioprosthesis
- Percutaneous Implantation of the CoreValve Self-Expanding Valve Prosthesis in High-Risk Patients With Aortic Valve Disease: The Siegburg First-in-Man Study
- Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?
- Society of Thoracic Surgeons score is superior to the EuroSCORE determining mortality in high risk patients undergoing isolated aortic valve replacement.
- Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document.
- Antithrombotic therapy after bioprosthetic aortic valve replacement: ACTION Registry survey results.
- Incidence and Predictors of Early and Late Mortality After Transcatheter Aortic Valve Implantation in 663 Patients With Severe Aortic Stenosis
- Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium.
- Anatomo-pathological analysis after CoreValve Revalving system implantation.
- Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2)
Cited by
- Atrial fibrillation following transcatheter aortic valve implantation: do we underestimate its frequency and impact?
- Platelet activation is less enhanced in the new balloon expandable Edwards Sapien 3 valve compared to its predecessor model (Edwards Sapien XT)
- Antithrombotic treatment in transcatheter aortic valve implantation: insights for cerebrovascular and bleeding events.
- Effect Modification of Interventions. Bridging the Gap Between Clinical Studies and the Individual Patient
- Endovascular and Hybrid Therapies for Structural Heart and Aortic Disease
- A prospective, non-randomized comparison of SAPIEN XT and CoreValve implantation in two sequential cohorts of patients with severe aortic stenosis.
- Pre-procedural dual antiplatelet therapy and bleeding events following transcatheter aortic valve implantation (TAVI).
- Stroke After Transcatheter Aortic Valve Replacement: Incidence, Risk Factors, Prognosis, and Preventive Strategies
- Variability in Antithrombotic Therapy Regimens Peri-TAVR: A Single Academic Center Experience
- Single vs Dual Antiplatelet Therapy Following Transcatheter Aortic Valve Implantation: A Systematic Review
- Neurologic Events After Transcatheter Aortic Valve Replacement.
- Clinical and prognostic implications of existing and new-onset atrial fibrillation in patients undergoing transcatheter aortic valve implantation
- Clopidogrel, aspirin and proton pump inhibition after percutaneous valve implants: an update.
- Antithrombotic therapy before, during and after transcatheter aortic valve replacement (TAVR)
- A Review of Antithrombotic Therapy for Transcatheter Aortic Valve Replacement
- Antithrombotic Strategies in Valvular and Structural Heart Disease Interventions: Current Status and Future Directions.
- Clinical ResearchInterventional CardiologyClinical Outcomes After Transcatheter Aortic Valve Replacement Using Valve Academic Research Consortium Definitions: A Weighted Meta-Analysis of 3,519 Patients From 16 Studies
- Dual versus single antiplatelet therapy in patients undergoing transcatheter aortic valve replacement: a systematic review and meta-analysis.
- Transcatheter aortic-valve replacement for inoperable severe aortic stenosis.
- Functional Status and Quality of Life After Transcatheter Aortic Valve Replacement: A Systematic Review
Related papers
- Role of clopidogrel in addition to aspirin in the prevention of recurrent ischaemic events in acute coronary syndrome with ST-segment elevation
- Antiplatelet Activity of Clopidogrel in Coronary Artery Bypass Graft Surgery Patients
- Increased mortality after coronary stenting in patients treated with clopidogrel without loading dose. Evidence from a meta-analysis.
- Thrombotic thrombocytopenic purpura associated with clopidogrel.
- Effect of clopidogrel on platelet function in patients with unstable angina pectoris
- Myelodysplastic syndrome associated with clopidogrel: a case report.
- Variability in Platelet Responsiveness to Clopidogrel Among 544 Individuals
- Clopidogrel: the future choice for preventing platelet activation during coronary stenting?
- Isolated profound thrombocytopenia associated with clopidogrel.